MCID: LNG030
MIFTS: 40

Lung Adenoma

Categories: Cancer diseases, Respiratory diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Lung Adenoma

MalaCards integrated aliases for Lung Adenoma:

Name: Lung Adenoma 11 14
Adenoma of Lung 11 71
Pulmonary Adenoma 11

Classifications:



External Ids:

Disease Ontology 11 DOID:5386
NCIt 49 C4455
SNOMED-CT 68 254642004
UMLS 71 C0345964

Summaries for Lung Adenoma

Disease Ontology: 11 A lung benign neoplasm that derives from glandular epithelial cells.

MalaCards based summary: Lung Adenoma, also known as adenoma of lung, is related to adenoma and lung benign neoplasm. An important gene associated with Lung Adenoma is C18orf54 (Chromosome 18 Open Reading Frame 54), and among its related pathways/superpathways are Apoptotic Pathways in Synovial Fibroblasts and ERK Signaling. Affiliated tissues include lung, skin and breast, and related phenotypes are Decreased viability and Synthetic lethal with MLN4924 (a NAE inhibitor)

Related Diseases for Lung Adenoma

Diseases related to Lung Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 388)
# Related Disease Score Top Affiliating Genes
1 adenoma 30.7 TP53 MYC KRAS HRAS CDKN2A CCND1
2 lung benign neoplasm 30.3 TP53 SFTPC SCGB1A1 KRAS HRAS EGFR
3 skin papilloma 29.4 TP53 PTEN MYC HRAS EGFR CCND1
4 adenocarcinoma 29.3 TP53 PTEN MAPK3 KRAS HRAS EGFR
5 papilloma 29.3 TP53 PTEN KRAS EGFR CDKN2A CCND1
6 lung squamous cell carcinoma 29.3 TP53 PTEN KRAS HRAS H2AC18 EGFR
7 lung cancer susceptibility 3 28.6 TP53 SFTPC SCGB1A1 RAF1 MYC KRAS
8 lung cancer 28.5 TP53 SCGB1A1 RAF1 PTEN MYC MIR30C1
9 common bile duct neoplasm 10.4 KRAS HRAS
10 ampulla of vater benign neoplasm 10.4 KRAS HRAS
11 vaginal carcinosarcoma 10.4 TP53 KRAS HRAS
12 bladder urachal carcinoma 10.4 KRAS HRAS
13 liver angiosarcoma 10.4 TP53 KRAS HRAS
14 cystadenofibroma 10.4 TP53 KRAS HRAS
15 endosalpingiosis 10.4 TP53 KRAS HRAS
16 hepatic flexure cancer 10.4 KRAS HRAS
17 appendix adenocarcinoma 10.4 TP53 KRAS HRAS
18 large cell carcinoma with rhabdoid phenotype 10.3 TP53 KRAS HRAS
19 urachus cancer 10.3 KRAS HRAS
20 pancreatic signet ring cell adenocarcinoma 10.3 TP53 KRAS HRAS
21 signet ring cell adenocarcinoma 10.3 TP53 KRAS HRAS
22 biliary tract benign neoplasm 10.3 TP53 KRAS HRAS
23 small intestine adenocarcinoma 10.3 TP53 KRAS HRAS
24 appendix disease 10.3 TP53 KRAS HRAS
25 endometrial mucinous adenocarcinoma 10.3 KRAS CDKN2A
26 appendix cancer 10.3 TP53 KRAS HRAS
27 ovarian benign neoplasm 10.3 TP53 KRAS HRAS
28 high-grade astrocytoma 10.3 TP53 PTEN
29 klatskin's tumor 10.3 TP53 KRAS HRAS
30 descending colon cancer 10.3 KRAS HRAS
31 villous adenoma 10.3 TP53 KRAS HRAS
32 papillary serous adenocarcinoma 10.3 TP53 KRAS HRAS
33 tonsillar pillar cancer 10.3 EGFR CDKN2A
34 duodenum cancer 10.3 TP53 KRAS HRAS
35 duodenum disease 10.3 TP53 KRAS HRAS
36 mucinous intrahepatic cholangiocarcinoma 10.3 KRAS HRAS
37 adenosquamous lung carcinoma 10.3 KRAS HRAS EGFR
38 bronchial benign neoplasm 10.3 SFTPC SCGB1A1 HRAS
39 cervical adenocarcinoma 10.3 TP53 KRAS CDKN2A
40 mucinous lung adenocarcinoma 10.3 KRAS HRAS EGFR
41 trachea carcinoma in situ 10.3 KRAS HRAS CDKN2A
42 b-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) 10.3 TP53 CDKN2A
43 sigmoid neoplasm 10.3 KRAS HRAS
44 papillary adenocarcinoma 10.3 TP53 KRAS HRAS
45 paronychia 10.3 KRAS HRAS EGFR
46 endometrial squamous cell carcinoma 10.3 TP53 CDKN2A
47 lung sarcomatoid carcinoma 10.3 KRAS HRAS EGFR
48 dermatopathia pigmentosa reticularis 10.3 KRAS HRAS EGFR
49 appendiceal neoplasm 10.3 KRAS HRAS
50 lung non-squamous non-small cell carcinoma 10.3 KRAS HRAS EGFR

Graphical network of the top 20 diseases related to Lung Adenoma:



Diseases related to Lung Adenoma

Symptoms & Phenotypes for Lung Adenoma

GenomeRNAi Phenotypes related to Lung Adenoma according to GeneCards Suite gene sharing:

25 (show all 19)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-1 10.47 EGFR HRAS KRAS
2 Decreased viability GR00055-A-2 10.47 EGFR HRAS KRAS
3 Decreased viability GR00055-A-3 10.47 KRAS
4 Decreased viability GR00106-A-0 10.47 KRAS
5 Decreased viability GR00221-A-1 10.47 AKT1 CDKN2A EGFR HRAS KRAS MYC
6 Decreased viability GR00221-A-2 10.47 AKT1 HRAS KRAS RAF1
7 Decreased viability GR00221-A-3 10.47 AKT1 CDKN2A HRAS MYC
8 Decreased viability GR00221-A-4 10.47 AKT1 CDKN2A EGFR
9 Decreased viability GR00249-S 10.47 AKT1 MYC
10 Decreased viability GR00301-A 10.47 KRAS RAF1
11 Decreased viability GR00381-A-1 10.47 KRAS
12 Decreased viability GR00402-S-2 10.47 MYC RAF1
13 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.84 AKT1 CDKN2A DNAI7 LMNTD1 MAPK3 PTEN
14 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.84 AKT1 CDKN2A DNAI7 LMNTD1 PTEN RAF1
15 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-3 9.84 MAPK3 TP53
16 Increased cell migration GR00055-A-1 9.46 MAPK3
17 Increased cell migration GR00055-A-3 9.46 MAPK3
18 Decreased viability with paclitaxel GR00179-A-1 9.26 EGFR MAPK3
19 Decreased viability with paclitaxel GR00179-A-3 9.26 EGFR MAPK3

MGI Mouse Phenotypes related to Lung Adenoma:

45 (show all 17)
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 10.4 AKT1 CCND1 CDKN2A DNAI7 EGFR HRAS
2 homeostasis/metabolism MP:0005376 10.34 AKT1 CCND1 CDKN2A DNAI7 EGFR HRAS
3 endocrine/exocrine gland MP:0005379 10.26 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
4 normal MP:0002873 10.25 AKT1 CCND1 EGFR HRAS KRAS MYC
5 muscle MP:0005369 10.22 AKT1 CDKN2A EGFR HRAS KRAS MAPK3
6 no phenotypic analysis MP:0003012 10.19 CDKN2A EGFR HRAS KRAS MIR30C1 MYC
7 liver/biliary system MP:0005370 10.16 AKT1 CDKN2A EGFR KRAS MAPK3 MYC
8 cardiovascular system MP:0005385 10.15 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
9 embryo MP:0005380 10.11 AKT1 CDKN2A EGFR KRAS MAPK3 MYC
10 immune system MP:0005387 10.1 AKT1 CCND1 CDKN2A EGFR KRAS MAPK3
11 digestive/alimentary MP:0005381 10.09 CCND1 CDKN2A EGFR HRAS KRAS MAPK3
12 pigmentation MP:0001186 10.04 CDKN2A EGFR KRAS MYC PTEN TP53
13 respiratory system MP:0005388 10.03 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
14 craniofacial MP:0005382 10.01 CCND1 EGFR HRAS KRAS MAPK3 MYC
15 skeleton MP:0005390 9.9 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
16 mortality/aging MP:0010768 9.8 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
17 integument MP:0010771 9.4 AKT1 CCND1 CDKN2A EGFR HRAS IRAG2

Drugs & Therapeutics for Lung Adenoma

Search Clinical Trials, NIH Clinical Center for Lung Adenoma

Genetic Tests for Lung Adenoma

Anatomical Context for Lung Adenoma

Organs/tissues related to Lung Adenoma:

MalaCards : Lung, Skin, Breast, Liver, Brain

Publications for Lung Adenoma

Articles related to Lung Adenoma:

(show top 50) (show all 328)
# Title Authors PMID Year
1
Assessing the Vulnerability of Cancer Patients for COVID-19. 62
36237732 2022
2
Iloprost requires the Frizzled-9 receptor to prevent lung cancer. 62
35707728 2022
3
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment. 62
34779486 2022
4
Molecular cytogenetic characterization of the urethane-induced murine lung cell line LA-4 as a model for human squamous cell lung cancer. 62
34881029 2022
5
Pulmonary Aerosol Delivery of Let-7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment. 62
34236760 2021
6
Coexposure to Inhaled Aldehydes or Carbon Dioxide Enhances the Carcinogenic Properties of the Tobacco-Specific Nitrosamine 4-Methylnitrosamino-1-(3-pyridyl)-1-butanone in the A/J Mouse Lung. 62
33629582 2021
7
Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation. 62
34805284 2021
8
Oral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J Mice. 62
32476407 2020
9
Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells. 62
32209656 2020
10
Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer. 62
31811110 2019
11
Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice. 62
30905765 2019
12
Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice. 62
30873838 2019
13
Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. 62
29572547 2019
14
CD44 facilitates adherence of Streptococcus equi subsp. zooepidemicus to LA-4 cells. 62
30639625 2019
15
Antitumor and anti-metastatic mechanisms of Rhizoma paridis saponins in Lewis mice. 62
29148169 2018
16
Mequindox Induced Genotoxicity and Carcinogenicity in Mice. 62
29692735 2018
17
Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016. 62
29636877 2018
18
Complex genetic control of lung tumorigenesis in resistant mice strains. 62
28796413 2017
19
The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model. 62
28851689 2017
20
p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer. 62
28745322 2017
21
Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis. 62
29191600 2017
22
The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation. 62
28811474 2017
23
High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice. 62
28535153 2017
24
An Evaluation of the Human Relevance of the Lung Tumors Observed in Female Mice Treated With Permethrin Based on Mode of Action. 62
28431163 2017
25
Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance. 62
28260069 2017
26
Inhibition of pulmonary carcinoma proliferation or metastasis of miR-218 via down-regulating CDCP1 expression. 62
28429357 2017
27
A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis. 62
28253859 2017
28
Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. 62
28052934 2017
29
Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice. 62
27993834 2017
30
[Metastatic pleomorphic adenoma of lung: report of a case]. 62
28072982 2017
31
Changes of serum amino acid profiles by an epidermal growth factor receptor mutation and benzo[a]pyrene in mouse lung tumorigenesis. 62
30090424 2016
32
Expression quantitative trait analysis reveals fine germline transcript regulation in mouse lung tumors. 62
26966001 2016
33
Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer. 62
27210750 2016
34
Uridine homeostatic disorder leads to DNA damage and tumorigenesis. 62
26801745 2016
35
Methyl methanesulfonate induces necroptosis in human lung adenoma A549 cells through the PIG-3-reactive oxygen species pathway. 62
26472723 2016
36
How do K-RAS-activated cells evade cellular defense mechanisms? 62
25961920 2016
37
Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice. 62
27293987 2016
38
Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. 62
26397133 2015
39
Inhibition of pulmonary adenoma in diethylnitrosamine-induced rats by Rhizoma paridis saponins. 62
26196122 2015
40
Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice. 62
26030593 2015
41
Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses. 62
25005685 2014
42
The error-prone DNA polymerase ι provides quantitative resistance to lung tumorigenesis and mutagenesis in mice. 62
23955086 2014
43
Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4A. 62
24743582 2014
44
Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells. 62
24959744 2014
45
ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway. 62
24671051 2014
46
Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice. 62
24403291 2014
47
Genetic linkage analysis identifies Pas1 as the common locus modulating lung tumorigenesis and acute inflammatory response in mice. 62
24067788 2013
48
Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice. 62
24106881 2013
49
β-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells. 62
23963803 2013
50
Xiao-Qing-Long-Tang shows preventive effect of asthma in an allergic asthma mouse model through neurotrophin regulation. 62
24010817 2013

Variations for Lung Adenoma

Expression for Lung Adenoma

Search GEO for disease gene expression data for Lung Adenoma.

Pathways for Lung Adenoma

Pathways related to Lung Adenoma according to GeneCards Suite gene sharing:

(show top 50) (show all 195)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.98 TP53 RAF1 PTEN MYC MAPK3 KRAS
2
Show member pathways
13.98 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
3 13.93 TP53 RAF1 PTEN MYC MAPK3 KRAS
4
Show member pathways
13.93 TP53 SFTPC RAF1 PTEN MYC MAPK3
5
Show member pathways
13.85 TP53 RAF1 MYC MAPK3 KRAS HRAS
6
Show member pathways
13.74 TP53 RAF1 MYC MAPK3 KRAS HRAS
7
Show member pathways
13.67 TP53 RAF1 MYC MAPK3 KRAS HRAS
8
Show member pathways
13.61 TP53 RAF1 PTEN MYC MAPK3 KRAS
9
Show member pathways
13.55 RAF1 PTEN MYC MAPK3 KRAS HRAS
10
Show member pathways
13.55 TP53 RAF1 PTEN KRAS HRAS EGFR
11
Show member pathways
13.52 AKT1 EGFR HRAS KRAS MAPK3 MYC
12
Show member pathways
13.45 RAF1 PTEN MAPK3 KRAS HRAS EGFR
13
Show member pathways
13.45 TP53 MYC MAPK3 KRAS HRAS CCND1
14
Show member pathways
13.25 TP53 RAF1 PTEN MAPK3 KRAS HRAS
15
Show member pathways
13.18 RAF1 MAPK3 KRAS HRAS EGFR AKT1
16
Show member pathways
13.17 MYC MAPK3 KRAS HRAS H2AC18 EGFR
17
Show member pathways
13.07 AKT1 HRAS KRAS MAPK3 RAF1 TP53
18
Show member pathways
13.07 RAF1 PTEN MAPK3 KRAS HRAS AKT1
19
Show member pathways
13.07 TP53 RAF1 PTEN MYC MAPK3 HRAS
20
Show member pathways
13.05 AKT1 CCND1 EGFR HRAS KRAS MAPK3
21
Show member pathways
13.04 AKT1 EGFR HRAS KRAS MAPK3 PTEN
22
Show member pathways
13.03 AKT1 CCND1 HRAS KRAS MAPK3 MYC
23
Show member pathways
13.01 RAF1 MAPK3 KRAS HRAS CCND1 AKT1
24
Show member pathways
13.01 RAF1 MAPK3 KRAS HRAS EGFR AKT1
25
Show member pathways
13.01 AKT1 CCND1 HRAS KRAS MAPK3 MYC
26
Show member pathways
13 RAF1 MAPK3 KRAS HRAS AKT1
27 12.99 AKT1 EGFR HRAS KRAS MAPK3 MYC
28
Show member pathways
12.95 AKT1 HRAS KRAS MAPK3 RAF1
29
Show member pathways
12.94 TP53 RAF1 MAPK3 KRAS HRAS AKT1
30
Show member pathways
12.93 TP53 MYC H2AC18 EGFR CCND1 AKT1
31
Show member pathways
12.91 RAF1 PTEN MAPK3 HRAS EGFR AKT1
32
Show member pathways
12.9 MAPK3 KRAS HRAS EGFR CCND1
33
Show member pathways
12.86 AKT1 EGFR HRAS KRAS MAPK3 RAF1
34
Show member pathways
12.85 TP53 RAF1 MAPK3 KRAS HRAS EGFR
35
Show member pathways
12.84 AKT1 EGFR HRAS KRAS MAPK3 RAF1
36
Show member pathways
12.84 AKT1 CDKN2A EGFR HRAS KRAS MAPK3
37
Show member pathways
12.81 AKT1 EGFR HRAS KRAS MAPK3 MYC
38
Show member pathways
12.8 RAF1 MAPK3 KRAS HRAS AKT1
39
Show member pathways
12.77 RAF1 MAPK3 KRAS HRAS EGFR
40
Show member pathways
12.77 TP53 MYC MAPK3 KRAS HRAS EGFR
41
Show member pathways
12.74 RAF1 MAPK3 HRAS CCND1 AKT1
42 12.74 TP53 RAF1 PTEN MYC MAPK3 HRAS
43
Show member pathways
12.68 RAF1 PTEN MAPK3 HRAS AKT1
44
Show member pathways
12.68 AKT1 CCND1 CDKN2A EGFR HRAS KRAS
45
Show member pathways
12.62 RAF1 MAPK3 KRAS HRAS EGFR AKT1
46
Show member pathways
12.62 AKT1 CCND1 HRAS MAPK3 PTEN RAF1
47
Show member pathways
12.61 TP53 RAF1 MYC MAPK3 KRAS HRAS
48
Show member pathways
12.6 AKT1 EGFR HRAS KRAS TP53
49 12.59 TP53 MYC MAPK3 CCND1 AKT1
50
Show member pathways
12.58 MYC CDKN2A CCND1 AKT1

GO Terms for Lung Adenoma

Cellular components related to Lung Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nuclear envelope GO:0005635 9.28 SCGB1A1 MYC MAPK3 LMNTD1 IRAG2

Biological processes related to Lung Adenoma according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell population proliferation GO:0008285 10.27 C18orf54 CDKN2A HRAS PTEN RAF1 TP53
2 positive regulation of cell population proliferation GO:0008284 10.22 AKT1 CCND1 EGFR HRAS KRAS MYC
3 positive regulation of gene expression GO:0010628 10.15 TP53 MYC MAPK3 KRAS HRAS CDKN2A
4 regulation of cell cycle GO:0051726 10.14 TP53 PTEN HRAS CDKN2A CCND1
5 Ras protein signal transduction GO:0007265 10.06 TP53 KRAS HRAS CDKN2A
6 MAPK cascade GO:0000165 10.03 EGFR HRAS KRAS MAPK3 MYC RAF1
7 positive regulation of G1/S transition of mitotic cell cycle GO:1900087 10.02 EGFR CCND1 AKT1
8 cellular response to reactive oxygen species GO:0034614 10 MAPK3 EGFR AKT1
9 cellular response to cadmium ion GO:0071276 9.99 MAPK3 EGFR AKT1
10 positive regulation of protein phosphorylation GO:0001934 9.77 RAF1 MAPK3 KRAS HRAS EGFR CCND1
11 insulin-like growth factor receptor signaling pathway GO:0048009 9.73 RAF1 MAPK3 AKT1
12 insulin receptor signaling pathway GO:0008286 9.72 RAF1 MAPK3 HRAS AKT1
13 cellular response to decreased oxygen levels GO:0036294 9.65 PTEN AKT1
14 response to UV-A GO:0070141 9.63 EGFR CCND1 AKT1
15 cell population proliferation GO:0008283 9.28 TP53 PTEN LMNTD1 KRAS EGFR CCND1

Molecular functions related to Lung Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 kinase activity GO:0016301 9.5 RAF1 MAPK3 EGFR CDKN2A CCND1 AKT1
2 enzyme binding GO:0019899 9.4 TP53 RAF1 PTEN EGFR CCND1 AKT1

Sources for Lung Adenoma

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....